“FACTORS DETERMINING THE CLINICAL SIGNIFICANCE OF DEPIPTIDYL PEPTIDASE 4 INHIBITORS IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS”, Wor.Bul.Pub.Helt., vol. 8, pp. 67–72, Mar. 2022, Accessed: Apr. 18, 2026. [Online]. Available: https://www.scholarexpress.net/index.php/wbph/article/view/651